Former Executive Vice President, Chief Financial Officer · Intellia Therapeutics, Inc. (NTLA)

Graeme Bell

A named executive officer of Intellia Therapeutics in every fiscal year CompBrief holds from FY2017 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$1,562,708

Salary $265,431Stock awards $337,238

FY2017: $3,797,912

5th of 5 named executive officers at Intellia Therapeutics by FY2018 total.

5 named officers on file for Intellia Therapeutics, FY2018

Graeme Bell’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • NTLA’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Intellia Therapeutics’s whole pay program stands against its peers

  • Intellia Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NTLA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 16, 2019 (DEF 14A).

Free

Get Graeme Bell’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Graeme Bell compensation by year

Intellia Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Intellia Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018
Salary$400,000$265,431
Bonus$178,480$0
Stock awards$0$337,238
Option awards$3,170,414$934,182
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$49,018$25,857
Total$3,797,912$1,562,708

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Intellia Therapeutics, Inc. DEF 14A filed April 16, 2019, accession 0001193125-19-107874, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Intellia Therapeutics, Inc. filed document, accession 0001193125-19-107874. Every figure is read from that document and cited to the page and table it appears in. Filed April 16, 2019.

$3.8M
$1.6M
FY17
FY18
SalaryBonusStock awardsOption awardsAll other

Intellia Therapeutics’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
John LeonardPresident, Chief Executive Officer$9,708,330
Andrew SchiermeierExecutive Vice President, Development and Corporate Strategy$2,925,306
José RiveraExecutive Vice President, General Counsel$2,646,896
Glenn GoddardExecutive Vice President, Chief Financial Officer$2,016,413
Graeme Bell · this pageFormer Executive Vice President, Chief Financial Officer$1,562,708

The full Intellia Therapeutics compensation record

free company brief

This page is one person within Intellia Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Intellia Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Intellia Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Graeme Bell's compensation dossier · One-time report. No refunds.